Dear Q,

PLEASE! PLEASE! MAKE THIS STOP! RELEASE THE CURES!

http://www.councilforresponsiblegenetics.org/pageDocuments/PLMVM6FTAO.pdf

Pay up to $700.00 a month or $15.00 per month. Really?

WHERE ARE YOU KANYE!

"The role of law as player in the emergence of BiDil as a race-specific drug began in 1980, more or less coincidentally with the initiation of V-HeFT I. That year, President Jimmy Carter signed into law two pieces of legislation that would come to transform relations between industry and academic researchers. The first, the Stevenson-Wydler Technology Transfer Act (15 U.S.C. § 3701 (1994)), encouraged interaction and cooperation among government laboratories, universities, big industries and small businesses. The second, the Bayh-Dole Patent and Trademark Laws Amendment (35 U.S.C. §§ 200-212 (1994)), allowed institutions conducting research with federal funds, such as universities, to retain the intellectual property rights to their discoveries."

"Moreover, given that the two drugs comprising BiDil were already available as generics, this also indicates how patent law and regulatory approval may distort a market, potentially obscuring less expensive generic alternatives that have the same therapeutic value."